Precision Testing. Trusted Results. Better Care.

American Scientific Laboratories

Provides advanced diagnostic testing with uncompromising accuracy and speed. From standard bloodwork to cutting-edge genetic sequencing, we help providers and facilities deliver evidence-based care. Our mission is to empower healthcare professionals with actionable results that improve outcomes, reduce costs, and enhance patient well-being.

Who We Serve

American Scientific Laboratories is uniquely positioned to support a wide range of healthcare providers and facilities, tailoring services to meet specific patient care needs:

Detox Centers – Reliable toxicology and bloodwork testing for patient monitoring during recovery.
Intensive Outpatient Treatment Centers – Reliable testing for compliance and relapse monitoring; as well as behavioral health programs.
Assisted Living Facilities – On-site phlebotomy with easy-to-access bloodwork and molecular testing to support elderly populations.
Concierge Medicine – Personalized diagnostic panels for preventative, individualized care to enhance patient-centered care models.
Wellness Clinics – Preventive and genetic testing through cutting-edge NGS and PGX testing to support proactive healthcare.
Reference Labs – Overflow and specialized testing partnerships with other laboratories.

Insurances We Accept

We Proudly Accept PPO Policies and Medicare

Bloodwork

Routine and specialized bloodwork remains one of the most critical diagnostic tools in modern medicine. Studies show that 70% of clinical decisions rely on laboratory results. We provide a full spectrum of testing that combines speed, accuracy, and clinical relevance; designed for detox centers, wellness providers, assisted living facilities, Proudly Accept PPO Policies and Medicare

and more.

Routine Bloodwork

Includes complete blood count (CBC), comprehensive metabolic panel (CMP), lipid panels, and more.

Essential for wellness checks, preventive care, and ongoing management of chronic conditions.

According to the CDC, 1 in 3 adults in the U.S. has undiagnosed high blood pressure or cholesterol that can be caught with routine labs

Chemistry

Evaluates electrolytes, liver and kidney function, enzymes, glucose, and other critical biochemical markers.

Provides insight into metabolic health, organ function, and disease progression.

Chemistry tests are critical for managing diabetes, heart disease, and liver/kidney disorders.

Immunoassay

Uses antibody-based technology to detect hormones, proteins, and specific biomarkers.

Common applications include thyroid testing, cardiac markers, fertility testing, and infectious disease screening.

Highly sensitive and enable early disease detection. Effective for both diagnostic and monitoring purposes.

Toxicology

Our laboratory provides advanced testing for substance detection and monitoring. Toxicology plays a critical role in addiction treatment, pain management, workplace safety, and medical compliance programs.

Presumptive Testing

Rapid initial drug screening using immunoassays.

Detects common drug classes (opioids, cannabinoids, stimulants, benzodiazepines, etc.).

Ideal for first-line screening in outpatient and detox settings.

Routine Drug Monitoring

Regular toxicology testing for patients on long-term prescriptions such as opioids, benzodiazepines, or stimulants.

Helps ensure patient compliance and treatment success.

Important in pain management: studies show up to 24% of patients prescribed opioids may misuse them (NIH).

Definitive Testing

Uses liquid chromatography–tandem mass spectrometry (LC-MS/MS) for precise, quantitative confirmation.

Confirms drug presence and quantifies concentrations with unmatched accuracy.

Crucial for compliance programs, pain management, and legal documentation.

Designer Drug Monitoring

Detects synthetic or “novel” psychoactive substances (e.g., synthetic cannabinoids, cathinones/"bath salts," fentanyl analogs).

Designed to keep pace with rapidly evolving drug trends.

Synthetic opioids contribute to the majority of the >90,000 overdose deaths annually in the U.S. (CDC).

Urine Screens

Cost-effective, non-invasive testing option for drug detection.

Can provide immediate results in clinical and non-clinical settings.

Suitable for detox centers, outpatient treatment programs, and assisted living facilities.

Custom Toxicology Panels

Tailored panels designed for specific provider needs (e.g., pain management, addiction medicine, or assisted living monitoring).

Can include emerging or less common substances.

Flexible design supports compliance with medical, legal, or program-specific requirements.

NSG Testing

Next-Generation Sequencing (NGS) allows for highly detailed analysis of a patient’s genetic profile, uncovering variations linked to disease predisposition, drug metabolism, and hereditary conditions.

A single NGS test can evaluate millions of DNA fragments in parallel, providing comprehensive results.

Preventive genetic testing is gaining traction: 1 in 3 adults in the U.S. has a family history of a genetic condition, according to the NIH.

Metabolic
Detects genetic variations contributing to inherited metabolic disorders, diabetes predisposition, and nutrient processing.

Useful for identifying conditions early in life and guiding diet/lifestyle interventions.

Over 1,400 rare metabolic conditions exist worldwide, many detectable via genetic panels.

Hereditary Neurological Disorders Risk
Detects mutations associated with Alzheimer’s, Parkinson’s, epilepsy, and other neurodegenerative or neurodevelopmental conditions.

Alzheimer’s alone affects 6.9 million Americans (2024 Alzheimer’s Association).

Genetic testing allows for earlier interventions and patient/family preparedness.

Pulmonary
Focuses on genetic predispositions to asthma, COPD, cystic fibrosis, and interstitial lung disease.

Respiratory diseases are among the top causes of death globally, affecting >500 million people worldwide.

Early detection allows for lifestyle modification, early treatment, and closer monitoring.

CGX (Cancer Genomics Testing)

Evaluates hereditary cancer risk through genes such as BRCA1/2, Lynch syndrome markers, and others.

About 5–10% of cancers are hereditary.

Enables preventive care and surveillance strategies for at-risk patients.

Thyroid
Identifies hereditary thyroid cancer syndromes and autoimmune thyroid conditions.Approximately 12% of Americans develop a thyroid condition in their lifetime.

Genetic insights can guide screening for family members at risk.

Primary Immunodeficiency
Identifies genetic factors contributing to autoimmune disorders and immune deficiencies.

Autoimmune diseases affect ~50 million Americans, predominantly women.

Genetic testing helps providers personalize treatment plans.

Molecular Testing

Molecular diagnostics, primarily using polymerase chain reaction (PCR), provide rapid and highly accurate detection of infectious agents and genetic markers. Turnaround times are often same-day, supporting faster clinical decisions.

Respiratory Panels

Simultaneously tests for multiple pathogens (e.g., influenza, RSV, SARS-CoV-2, adenovirus).

Faster than culture methods, with results available in hours instead of days.

Respiratory illnesses cause ~3 million deaths globally per year (WHO).

Infectious Disease

Detects a broad range of viral and bacterial pathogens (e.g., sexually transmitted infections, gastrointestinal pathogens).

Offers faster turnaround than culture, supporting timely intervention.

UTI through PCR

Detects urinary pathogens with higher sensitivity than traditional urine culture.

Can identify polymicrobial infections missed by standard culture methods.

UTIs account for 8.1 million healthcare visits annually in the U.S. (CDC).

CGX (Cancer Genomics Testing)

Evaluates hereditary cancer risk through genes such as BRCA1/2, Lynch syndrome markers, and others.

About 5–10% of cancers are hereditary.

Enables preventive care and surveillance strategies for at-risk patients.

Antibiotic Resistance

Identifies resistance genes in bacteria, guiding targeted antibiotic therapy.

Reduces the risk of ineffective treatment and supports antimicrobial stewardship.

Antibiotic resistance is a growing global crisis: the CDC estimates 2.8 million infections annually in the U.S. are antibiotic-resistant.

Primary Immunodeficiency
Identifies genetic factors contributing to autoimmune disorders and immune deficiencies.

Autoimmune diseases affect ~50 million Americans, predominantly women.

Genetic testing helps providers personalize treatment plans.

STD Testing

Chlamydia & Gonorrhea

Nucleic acid amplification testing (NAAT) provides highly sensitive and specific detection.
CDC recommends annual screening for sexually active individuals under 25, as well as those at higher risk.

Untreated infections can lead to infertility, pelvic inflammatory disease, and chronic pelvic pain.

Syphilis (RPR & Confirmatory Testing)

Detects a broad range of viral and bacterial pathogens (e.g., sexually transmitted infections, gastrointestinal pathogens).

Offers faster turnaround than culture, supporting timely intervention.

HIV Testing

Includes 4th-generation antigen/antibody testing for early detection.

HIV affects over 1.2 million Americans, with approximately 13% undiagnosed.

Early diagnosis allows for timely treatment that can suppress viral load to undetectable levels.

CGX (Cancer Genomics Testing)

Evaluates hereditary cancer risk through genes such as BRCA1/2, Lynch syndrome markers, and others.

About 5–10% of cancers are hereditary.

Enables preventive care and surveillance strategies for at-risk patients.

Hepatitis B & C

Identifies resistance genes in bacteria, guiding targeted antibiotic therapy.

Reduces the risk of ineffective treatment and supports antimicrobial stewardship.

Antibiotic resistance is a growing global crisis: the CDC estimates 2.8 million infections annually in the U.S. are antibiotic-resistant.

Primary Immunodeficiency
Identifies genetic factors contributing to autoimmune disorders and immune deficiencies.

Autoimmune diseases affect ~50 million Americans, predominantly women.

Genetic testing helps providers personalize treatment plans.

3380 Fairlane Farms Rd, Wellington, FL 33414, USA

We 're honored you've trusted ASL Laboratories with your trusting needs. Our team is committed to delivering accurate, timely genetic and diagnostic results with compassionate, concierge-style service. By choosing ASL, you're partnering with a laboratory that values precision, privacy and personalized support-helping you and your patients make informed decisions with confidence.